Form 8-K - Current report:
SEC Accession No. 0001104659-25-027444
Filing Date
2025-03-25
Accepted
2025-03-25 06:05:11
Documents
16
Period of Report
2025-03-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2510181d1_8k.htm   iXBRL 8-K 32789
2 EXHIBIT 99.1 tm2510181d1_ex99-1.htm EX-99.1 17794
6 GRAPHIC tm2510181d1_ex99-1img001.jpg GRAPHIC 2928
7 GRAPHIC tm2510181d1_ex99-1img002.jpg GRAPHIC 2477
  Complete submission text file 0001104659-25-027444.txt   240002

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alms-20250325.xsd EX-101.SCH 3009
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alms-20250325_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alms-20250325_pre.xml EX-101.PRE 22355
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2510181d1_8k_htm.xml XML 3679
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Filer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42143 | Film No.: 25765628
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)